161 related articles for article (PubMed ID: 37704550)
21. Etiology of hypopituitarism in tertiary care institutions in Turkish population: analysis of 773 patients from Pituitary Study Group database.
Tanriverdi F; Dokmetas HS; Kebapcı N; Kilicli F; Atmaca H; Yarman S; Ertorer ME; Erturk E; Bayram F; Tugrul A; Culha C; Cakir M; Mert M; Aydin H; Taskale M; Ersoz N; Canturk Z; Anaforoglu I; Ozkaya M; Oruk G; Hekimsoy Z; Kelestimur F; Erbas T
Endocrine; 2014 Sep; 47(1):198-205. PubMed ID: 24366641
[TBL] [Abstract][Full Text] [Related]
22. Progression from isolated growth hormone deficiency to combined pituitary hormone deficiency.
Cerbone M; Dattani MT
Growth Horm IGF Res; 2017 Dec; 37():19-25. PubMed ID: 29107171
[TBL] [Abstract][Full Text] [Related]
23. Hypopituitarism.
Fleseriu M; Christ-Crain M; Langlois F; Gadelha M; Melmed S
Lancet; 2024 Jun; 403(10444):2632-2648. PubMed ID: 38735295
[TBL] [Abstract][Full Text] [Related]
24. High-Performance Liquid Chromatography-Mass Spectrometry-based Metabolic Profiling of Adult Growth Hormone Deficiency.
Yang H; Chen M; Wang Y; Jiang L; Wang L; Duan L; Gong F; Zhu H; Pan H
J Clin Endocrinol Metab; 2023 Aug; 108(9):2272-2281. PubMed ID: 36883594
[TBL] [Abstract][Full Text] [Related]
25. [Diagnosis and treatment of adult growth hormone deficiency (aGHD) resulting from brain injury--role of aGHD].
Arita K; Hirano H; Tominaga A; Kurisu K
Brain Nerve; 2008 Dec; 60(12):1445-54. PubMed ID: 19110756
[TBL] [Abstract][Full Text] [Related]
26. "Non-Classical" Indication for Provocative Testing of Growth Hormone: A Retrospective Cohort Study in Adult Patients Under Replacement Therapy.
Mancini A; Bruno C; Vergani E; Brunetti A; Palmisano G; Pontecorvi A
Endocr Metab Immune Disord Drug Targets; 2021; 21(8):1406-1412. PubMed ID: 32990548
[TBL] [Abstract][Full Text] [Related]
27. Growth hormone deficiency with late-onset hypothalamic hypoadrenocorticism associated with respiratory and renal dysfunction: a case report.
Kojima N; Koriyama N; Tokito A; Ogiso K; Kusumoto K; Kubo S; Nishio Y
BMC Endocr Disord; 2020 Apr; 20(1):50. PubMed ID: 32299407
[TBL] [Abstract][Full Text] [Related]
28. Characteristic features of 20 patients with Sheehan's syndrome.
Dökmetaş HS; Kilicli F; Korkmaz S; Yonem O
Gynecol Endocrinol; 2006 May; 22(5):279-83. PubMed ID: 16785150
[TBL] [Abstract][Full Text] [Related]
29. Long-term Safety of Growth Hormone in Adults With Growth Hormone Deficiency: Overview of 15 809 GH-Treated Patients.
Johannsson G; Touraine P; Feldt-Rasmussen U; Pico A; Vila G; Mattsson AF; Carlsson M; Korbonits M; van Beek AP; Wajnrajch MP; Gomez R; Yuen KCJ
J Clin Endocrinol Metab; 2022 Jun; 107(7):1906-1919. PubMed ID: 35368070
[TBL] [Abstract][Full Text] [Related]
30. A primer on pituitary injury for the obstetrician gynecologist: Simmond's disease, Sheehan's Syndrome, traumatic injury, Dahan's Syndrome, pituitary apoplexy and lymphocytic hypophysitis.
Dahan MH; Tan SL
Minerva Ginecol; 2017 Apr; 69(2):190-194. PubMed ID: 27405776
[TBL] [Abstract][Full Text] [Related]
31. Growth hormone deficiency in adults with hypopituitarism-What are the risks and can they be eliminated by therapy?
Johannsson G; Ragnarsson O
J Intern Med; 2021 Dec; 290(6):1180-1193. PubMed ID: 34605087
[TBL] [Abstract][Full Text] [Related]
32. Meta-analysis of mortality in adults with growth hormone deficiency: Does growth hormone replacement therapy really improve mortality rates?
van Bunderen CC; Olsson DS
Best Pract Res Clin Endocrinol Metab; 2023 Dec; 37(6):101835. PubMed ID: 37914564
[TBL] [Abstract][Full Text] [Related]
33. The consequences of growth hormone deficiency in adulthood, and the effects of growth hormone replacement.
Christ ER; Carroll PV; Russell-Jones DL; Sönksen PH
Schweiz Med Wochenschr; 1997 Aug; 127(35):1440-9. PubMed ID: 9297747
[TBL] [Abstract][Full Text] [Related]
34. Isolated anterior pituitary dysfunction in adulthood.
Prencipe N; Marinelli L; Varaldo E; Cuboni D; Berton AM; Bioletto F; Bona C; Gasco V; Grottoli S
Front Endocrinol (Lausanne); 2023; 14():1100007. PubMed ID: 36967769
[TBL] [Abstract][Full Text] [Related]
35. Long-term safety of growth hormone replacement therapy in survivors of cancer and tumors of the pituitary region.
Bolier M; van der Lelij AJ; Janssens GO; van den Heuvel-Eibrink MM; Neggers SJCMM
Endocr Relat Cancer; 2023 Jul; 30(7):. PubMed ID: 37043373
[TBL] [Abstract][Full Text] [Related]
36. Alternative causes of hypopituitarism: traumatic brain injury, cranial irradiation, and infections.
Pekic S; Popovic V
Handb Clin Neurol; 2014; 124():271-90. PubMed ID: 25248593
[TBL] [Abstract][Full Text] [Related]
37. Pregnancy and other pituitary disorders (including GH deficiency).
Karaca Z; Kelestimur F
Best Pract Res Clin Endocrinol Metab; 2011 Dec; 25(6):897-910. PubMed ID: 22115165
[TBL] [Abstract][Full Text] [Related]
38. Clinical report of 28 patients with Sheehan's syndrome.
Sert M; Tetiker T; Kirim S; Kocak M
Endocr J; 2003 Jun; 50(3):297-301. PubMed ID: 12940458
[TBL] [Abstract][Full Text] [Related]
39. Once-weekly Somapacitan is Effective and Well Tolerated in Adults with GH Deficiency: A Randomized Phase 3 Trial.
Johannsson G; Gordon MB; Højby Rasmussen M; Håkonsson IH; Karges W; Sværke C; Tahara S; Takano K; Biller BMK
J Clin Endocrinol Metab; 2020 Apr; 105(4):e1358-76. PubMed ID: 32022863
[TBL] [Abstract][Full Text] [Related]
40. Association between pituitary height and growth response to recombinant human growth hormone in prepubertal children with growth hormone deficiency.
Zhang Z; Zhang X; Niu W; Yuan Y
Endocrine; 2023 Feb; 79(2):287-291. PubMed ID: 36264534
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
